Terrence "Terry" Dahl, ’83 PhD, is Vice President, Commercial Manufacturing and Packaging/Labeling, at Gilead Sciences. He leads a team in Foster City, Calif. that is responsible for overseeing the contract manufacturing activities throughout Europe, North America, and Australia. In addition, he has responsibility for an aseptic manufacturing site and solid oral dosage form packaging site in San Dimas, Calif. and a manufacturing and packaging/labeling site in Cork, Ireland. Dahl previously was Senior Director in Pharmaceutical Development and Manufacturing with responsibilities including overseeing formulation and process development, scale-up, clinical packaging/labeling, and managing the pilot plant.
Dahl joined Gilead Sciences in 1995 as a Senior Scientist and has been involved in the development of a number of Gilead’s marketed products. He previously was at Syntex Laboratories (Palo Alto, Ca.) in the formulation and process development area from 1983 to 1995. Dahl is the author of more than ten scientific publications and is also the holder of several patents. He is a member of the American Association of Pharmaceutical Scientists (AAPS).
Dahl received his BS degree in Pharmacy from North Dakota State University in 1977 and holds a PhD in Physical Pharmacy from the University of Iowa. He holds pharmacy licenses in California, Iowa, Montana, and North Dakota. Terry and his wife, Donna, reside in Sunnyvale, Calif.